Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
Cancer Biology & Therapy
|
November 14, 2003
Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism
Andrea L Volk, Angel A Rivera, Anna Kanerva, et al.
Cancer
|
September 2, 2006
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer
Merja Sarkioja, Anna Kanerva, Jarmo Salo, et al.
Plos One
|
November 17, 2010
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus
Laura Ahtiainen, Cristina Mirantes, Tiina Jahkola, et al.
Journal of Translational Medicine
|
August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Mari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors
Anna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 10, 2015
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues
Anniina Koski, Simona Bramante, Anja Kipar, et al.
The Journal of Gene Medicine
|
May 5, 2010
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir
Iulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, et al.
Cancer Research
|
March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinoma
Gerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Molecular Cancer Therapeutics
|
October 17, 2007
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Kilian Guse, Tuuli Ranki, Martti Ala-Opas, et al.
Oncoimmunology
|
May 8, 2015
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
Cancer Biology & Therapy
|
November 14, 2003
Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism
Andrea L Volk, Angel A Rivera, Anna Kanerva, et al.
Cancer
|
September 2, 2006
Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer
Merja Sarkioja, Anna Kanerva, Jarmo Salo, et al.
Plos One
|
November 17, 2010
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus
Laura Ahtiainen, Cristina Mirantes, Tiina Jahkola, et al.
Journal of Translational Medicine
|
August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment
Mari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors
Anna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 10, 2015
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues
Anniina Koski, Simona Bramante, Anja Kipar, et al.
The Journal of Gene Medicine
|
May 5, 2010
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir
Iulia Diaconu, Vincenzo Cerullo, Sophie Escutenaire, et al.
Cancer Research
|
March 13, 2002
The flt-1 promoter for transcriptional targeting of teratocarcinoma
Gerd J Bauerschmitz, Dirk M Nettelbeck, Anna Kanerva, et al.
Molecular Cancer Therapeutics
|
October 17, 2007
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Kilian Guse, Tuuli Ranki, Martti Ala-Opas, et al.
Oncoimmunology
|
May 8, 2015
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, et al.
Page
of 13